Table 3 Comparison of clinical parameters of the control and TAVNS groups at baseline and after 8-weeks of follow-up

Weight (Kg)

104 ± 22

103 ± 22

105 ± 18

105 ± 18

0.172

AC (cm)

122 ± 13

119 ± 15

119 ± 12

118 ± 11

0.332

BIM (Kg/m2)

37 ± 6

36 ± 6

37 ± 5

37 ± 5

0.126

SBP(mmHg)

135 ± 21

133 ± 21

137 ± 21

121 ± 11^#

0.028*

DBP (mmHg)

80 ± 10

83 ± 10

81 ± 10

77 ± 8^#

0.007*

HR (bpm)

74 ± 10

76 ± 10

72 ± 7

68 ± 8^#

0.034*

HRV

 VARR

2137 ± 1988

2060 ± 2065

2749 ± 2793

3621 ± 4092

0.279

 RMSSD (ms)

34 ± 21

33 ± 24

41 ± 28

51 ± 41

0.181

 LF abs (ms²)

666 ± 662

576 ± 666

772 ± 839

710 ± 846

0.889

 HF abs (ms²)

595 ± 594

560 ± 677

896 ± 1362

1530 ± 2485

0.154

 LF%

34 ± 6

36 ± 9

32 ± 7

26 ± 8^#

0.037*

 HF%

29 ± 14

28 ± 11

34 ± 14

43 ± 19^#

0.046*

SBPV

 Variance

51 ± 34

32 ± 24

36 ± 28

33 ± 16

0.204